An update of phase II results from RTOG 0211: A phase I/II study of Gefitinib plus radiation for newly-diagnosed glioblastoma patients

被引：4
|
作者：
Chakravarti, A.
Berkey, B.
Robins, H. I.
Guha, A.
Curran, W.
Brachman, D.
Shultz, C.
Mehta, M.
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Amer Coll Radiol, Philadelphia, PA USA
[3] Univ Wisconsin, Madison, WI USA
[4] Univ Toronto, Toronto, ON, Canada
[5] Thomas Jefferson Med Coll, Philadelphia, PA USA
[6] Fdn Canc Res, Phoenix, AZ USA
[7] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2006年 / 66卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2006.07.180
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
149
引用
收藏
页码：S83 / S84
页数：2
相关论文
共 50 条
  • [41] Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study
    Navarria, Pierina
    Pessina, Federico
    Tomatis, Stefano
    Soffietti, Riccardo
    Grimaldi, Marco
    Lopci, Egesta
    Chiti, Arturo
    Leonetti, Antonella
    Casarotti, Alessandra
    Rossi, Marco
    Cozzi, Luca
    Ascolese, Anna Maria
    Simonelli, Matteo
    Marcheselli, Simona
    Santoro, Armando
    Clerici, Elena
    Bello, Lorenzo
    Scorsetti, Marta
    ONCOTARGET, 2017, 8 (40) : 67696 - 67708
  • [42] SurVaxM with standard therapy in newly diagnosed glioblastoma: Phase II trial update.
    Ahluwalia, Manmeet Singh
    Reardon, David A.
    Abad, Ajay P.
    Curry, William T.
    Wong, Eric T.
    Belal, Ahmed
    Qiu, Jingxin
    Mogensen, Kathleen
    Schilero, Cathy
    Hutson, Alan
    Casucci, Danielle
    Mechtler, Laszlo
    Uhlmann, Erik J.
    Ciesielski, Michael J.
    Fenstermaker, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [43] Phase I/II study of dianhydrogalactitol (VAL-083) with radiation therapy in patients with newly diagnosed, MGMT-unmethylated glioblastoma
    Chen, Zhong-ping
    Guo, Chengcheng
    Bacha, Jeffrey
    Langlands, John
    Steino, Anne
    Kwan, Claire
    Kanekal, Sarath
    Schwartz, Richard
    Lopez, Lorena
    Brown, Dennis
    CANCER RESEARCH, 2019, 79 (13)
  • [44] Phase I/II study of dianhydrogalactitol (VAL-083) with radiation therapy in patients with newly diagnosed glioblastoma, MGMT-unmethylated
    Chen, Zhong-ping
    Guo, Chengcheng
    Bacha, Jeffrey
    Steino, Anne
    Langlands, John
    Kwan, Claire
    Kanekal, Sarath
    Schwartz, Richard
    Lopez, Lorena
    Brown, Dennis M.
    CANCER RESEARCH, 2018, 78 (13)
  • [45] Gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme (GBM): Preliminary results of a phase II study
    Fabi, Alessandra
    Mirri, Alessandra
    Pace, Andrea
    Felici, Alessandra
    Vidiri, Antonello
    Metro, Giulio
    Cognetti, Francesco
    Occhipinti, Emanuele
    Arcangeli, Giorgio
    Carapella, Carmine
    NEURO-ONCOLOGY, 2007, 9 (04) : 530 - 530
  • [46] Phase I/II study of pazopanib and temozolomide in patients with newly diagnosed and resected glioblastoma: Pazoglio trial.
    Saada-Bouzid, Esma
    Frenel, Jean-Sebastien
    Augereau, Paule
    Bourg, Veronique
    Gal, Jocelyn
    Jacquinot, Rique
    Gourmelon, Carole
    Chateau, Yann
    Barriere, Jerome
    Bondiau, Pierre-Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [47] Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy in patients with newly diagnosed glioblastoma
    Ryu, Samuel
    Ye, Xiaobu
    Olson, Jeffrey J.
    Mikkelsen, Tom
    Bangiyev, Lev
    Lesser, Glenn J.
    Batchelor, Tracy
    Nabors, Burt
    Desideri, Serena
    Walbert, Tobias
    Grossman, Stuart A.
    NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)
  • [48] Phase II study of chemotherapy with ACNU plus cisplatin followed by cranial irradiation in patients with newly diagnosed glioblastoma multiforme
    Choi, IS
    Lee, SH
    Kim, TY
    Bang, JS
    Paek, SH
    Kim, S
    Kim, IH
    Heo, DS
    Bang, YJ
    Kim, DG
    Jung, HW
    Kim, NK
    JOURNAL OF NEURO-ONCOLOGY, 2002, 60 (02) : 171 - 176
  • [49] Phase II study of chemotherapy with ACNU plus cisplatin followed by cranial irradiation in patients with newly diagnosed glioblastoma multiforme
    Sil Choi I.
    Hoon Lee S.
    Kim T.-Y.
    Seug Bang J.
    Ha Paek S.
    Kim S.
    Han Kim I.
    Seog Heo D.
    Bang Y.-J.
    Gyu Kim D.
    Jung H.-W.
    Kyeong Kim N.
    Journal of Neuro-Oncology, 2002, 60 (2) : 171 - 176
  • [50] A PHASE 0 'TRIGGER' TRIAL OF NIRAPARIB IN NEWLY-DIAGNOSED GLIOBLASTOMA PATIENTS
    Sanai, Nader
    Margaryan, Tigran
    Molloy, Jennifer
    Knight, William
    Harmon, Jocelyn
    Hong, Amy
    Wanebo, John
    Kennedy, William
    Garcia, Michael
    Barani, Igor
    Yoo, Wonsuk
    Tien, An-Chi
    Tovmasyan, Artak
    Mehta, Shwetal
    NEURO-ONCOLOGY, 2022, 24 : 73 - 73
12345